The human ribosomal protein S2 (RPS2), which has been implicated in multiple types of tumours [137], contains an N-terminal arginine and glycine-rich repeat region targeted by PAD4 for citrullination [137] and PRMT3 for methylation [138–140]. Here, PADI4 is linked to neoplasm.